191 related articles for article (PubMed ID: 37343519)
81. Evaluating the evidence for over-the-counter alternatives for relief of hot flashes in menopausal women.
Kelley KW; Carroll DG
J Am Pharm Assoc (2003); 2010; 50(5):e106-15. PubMed ID: 20833608
[TBL] [Abstract][Full Text] [Related]
82. A pilot study to examine a combination botanical for the treatment of menopausal symptoms.
Smolinski D; Wollner D; Orlowski J; Curcio J; Nevels J; Kim LS
J Altern Complement Med; 2005 Jun; 11(3):483-9. PubMed ID: 15992234
[TBL] [Abstract][Full Text] [Related]
83. 'Feeling hot, hot, hot': is there a role for exercise in the management of vasomotor and other menopausal symptoms?
Daley AJ; Stokes-Lampard H; MacArthur C
J Fam Plann Reprod Health Care; 2007 Jul; 33(3):143-5. PubMed ID: 17609065
[No Abstract] [Full Text] [Related]
84. Deal watch: Neurokinin 3 receptor antagonist revival heats up with Astellas acquisition.
Cully M
Nat Rev Drug Discov; 2017 May; 16(6):377. PubMed ID: 28559557
[No Abstract] [Full Text] [Related]
85. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women.
Naunton M; Al Hadithy AF; Brouwers JR; Archer DF
Menopause; 2006; 13(3):517-27. PubMed ID: 16735950
[TBL] [Abstract][Full Text] [Related]
86. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women.
Lai JN; Hwang JS; Chen HJ; Wang JD
J Altern Complement Med; 2005 Dec; 11(6):1075-84. PubMed ID: 16398600
[TBL] [Abstract][Full Text] [Related]
87. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
88. Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.
Brunner RL; Aragaki A; Barnabei V; Cochrane BB; Gass M; Hendrix S; Lane D; Ockene J; Woods NF; Yasmeen S; Stefanick M
Menopause; 2010; 17(5):946-54. PubMed ID: 20505547
[TBL] [Abstract][Full Text] [Related]
89. ERAAs for menopause treatment: Welcome the 'designer estrogens'.
Hirsch HD; Shih E; Thacker HL
Cleve Clin J Med; 2017 Jun; 84(6):463-470. PubMed ID: 28628428
[TBL] [Abstract][Full Text] [Related]
90. Perspective on menopausal vasomotor symptoms, CAM, and the SWAN.
Pinkerton JV; Pastore LM
Menopause; 2007; 14(4):601-5. PubMed ID: 17529901
[No Abstract] [Full Text] [Related]
91. Initial 17beta-estradiol dose for treating vasomotor symptoms.
Notelovitz M; Lenihan JP; McDermott M; Kerber IJ; Nanavati N; Arce J
Obstet Gynecol; 2000 May; 95(5):726-31. PubMed ID: 10775738
[TBL] [Abstract][Full Text] [Related]
92. Duloxetine for major depressive disorder and daytime and nighttime hot flashes associated with the menopausal transition.
Freeman MP; Hirschberg AM; Wang B; Petrillo LF; Connors S; Regan S; Joffe H; Cohen LS
Maturitas; 2013 Jun; 75(2):170-4. PubMed ID: 23602542
[TBL] [Abstract][Full Text] [Related]
93. A prospective study of DT56a (Femarelle®) for the treatment of menopause symptoms.
Sánchez-Borrego R; Mendoza N; Llaneza P
Climacteric; 2015; 18(6):813-6. PubMed ID: 26455645
[TBL] [Abstract][Full Text] [Related]
94. Another option for menopausal vasomotor symptoms without negative impact on weight and sexual function.
Bachmann G
Menopause; 2014 Oct; 21(10):1036-7. PubMed ID: 25072955
[No Abstract] [Full Text] [Related]
95. Anxiety during the menopausal transition: a systematic review.
Bryant C; Judd FK; Hickey M
J Affect Disord; 2012 Jul; 139(2):141-8. PubMed ID: 21783260
[TBL] [Abstract][Full Text] [Related]
96. Scaffold hopping of fused piperidine-type NK3 receptor antagonists to reduce environmental impact.
Yamamoto K; Inuki S; Ohno H; Oishi S
Bioorg Med Chem; 2019 May; 27(10):2019-2026. PubMed ID: 30975505
[TBL] [Abstract][Full Text] [Related]
97. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
Pinkerton JV; Joffe H; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
Menopause; 2015 Jan; 22(1):50-8. PubMed ID: 25137243
[TBL] [Abstract][Full Text] [Related]
98. Safety of non-hormonal medications for managing hot flashes.
De Franciscis P; Guida M; Schiattarella A; Riemma G; Colacurci N
Expert Opin Drug Saf; 2022 Feb; 21(2):215-221. PubMed ID: 34304686
[TBL] [Abstract][Full Text] [Related]
99. [Feminorm good night to treat the menopause].
Malinova M
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():7-10. PubMed ID: 22524131
[TBL] [Abstract][Full Text] [Related]
100. Drugs for menopausal symptoms.
Med Lett Drugs Ther; 2012 May; 54(1391):41-3. PubMed ID: 22643440
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
